Composition For Nasal Application With Improved Stability

Patent No. EP2818163 (titled "Composition For Nasal Application With Improved Stability") was filed by Maria Clementine Martin Klosterfrau Vertriebsgesellschaft on Sep 25, 2012. The application was issued on Jun 26, 2024.

Patent Summary

A pharmaceutical composition for treating rhinitis that provides enhanced stability through the use of a preservative system. The composition contains a combination of an imidazoline-based alpha-sympathomimetic and pantothenic acid, with the alpha-sympathomimetic component being a physiologically acceptable salt of xylometazoline. The preservative system, which includes benzalkonium chloride, enables the formulation to maintain its active ingredient concentrations while preventing degradation. This composition is particularly effective for topical intranasal applications, including nasal sprays and nasal drops, and is suitable for treating acute and chronic rhinitis.

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2818163

MARIA CLEMENTINE MARTIN KLOSTERFRAU VERTRIEBSGESELLSCHAFT
Application Number
EP14182601A
Filing Date
Sep 25, 2012
Status
Granted And Under Opposition
May 24, 2024
Publication Date
Jun 26, 2024